Reply to Woltsche N. et al . Managing adverse effects by dose reduction during routine treatment of locally advanced basal cell carcinoma with the hedgehog inhibitor vismodegib: a single‐centre experience-Reference-Cited by-同舟云学术

Reply to Woltsche N. et al . Managing adverse effects by dose reduction during routine treatment of locally advanced basal cell carcinoma with the hedgehog inhibitor vismodegib: a single‐centre experience

Published:2019-03-20 Issue:4 Volume:33 Page:
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:J Eur Acad Dermatol Venereol

Author:

Scalvenzi M.¹,Costa C.¹,Cappello M.¹,Villani A.¹

Affiliation:

1. Department of Dermatology University of Naples Federico II Naples Italy

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.15469

Reference5 articles.

1. Managing adverse effects by dose reduction during routine treatment of locally advanced basal cell carcinoma with the hedgehog inhibitor vismodegib: a single centre experience

2. Characterization and Management of Hedgehog Pathway Inhibitor-Related Adverse Events in Patients With Advanced Basal Cell Carcinoma

3. Two intermittent vismodegib dosing regimens in patients with multiple basal-cell carcinomas (MIKIE): a randomised, regimen-controlled, double-blind, phase 2 trial

4. Vismodegib persistence and discontinuation patterns in Greek patients from a real world setting

5. Managing adverse events associated with vismodegib in the treatment of basal cell carcinoma

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Approaches for Non-Melanoma Skin Cancer: Standard of Care and Emerging Modalities;International Journal of Molecular Sciences;2024-06-27

2. Evaluation of the Tolerability of Hedgehog Pathway Inhibitors in the Treatment of Advanced Basal Cell Carcinoma: A Narrative Review of Treatment Strategies;American Journal of Clinical Dermatology;2024-06-19

3. Vismodegib in Gorlin‐Goltz syndrome: A systematic review;Australasian Journal of Dermatology;2024-06-12

4. An update on the current and emerging pharmacotherapies for basal cell carcinomas;Expert Opinion on Pharmacotherapy;2023-11-18

5. Medication-induced hair loss: An update;Journal of the American Academy of Dermatology;2023-08